Key Points
- Kenvue General Counsel Matthew Orlando sold 38,491 shares on May 8 for about $679,751, at an average price of $17.66 per share, according to an SEC filing.
- The company recently beat quarterly expectations, reporting EPS of $0.32 versus $0.27 expected and revenue of $3.91 billion versus $3.84 billion expected, with revenue up 4.5% year over year.
- Kenvue also announced a quarterly dividend of $0.2075 per share, which implies an annualized yield of about 4.8%; however, the payout ratio is high at 97.65%.
Kenvue Inc. (NYSE:KVUE - Get Free Report) General Counsel Matthew Orlando sold 38,491 shares of the business's stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Kenvue Stock Up 1.7%
KVUE stock opened at $17.47 on Wednesday. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $33.54 billion, a PE ratio of 20.55, a PEG ratio of 1.30 and a beta of 0.55. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $24.35. The business's 50 day simple moving average is $17.55 and its 200 day simple moving average is $17.29.
Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm's quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.24 EPS. As a group, research analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.
Kenvue Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue's payout ratio is 97.65%.
Analyst Upgrades and Downgrades
KVUE has been the subject of several recent research reports. Canaccord Genuity Group boosted their price target on Kenvue from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Wednesday, February 18th. Weiss Ratings upgraded Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday. Zacks Research upgraded Kenvue from a "hold" rating to a "strong-buy" rating in a research note on Friday, May 8th. Barclays reduced their price target on Kenvue from $19.00 to $18.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 14th. Finally, Argus upgraded Kenvue to a "hold" rating in a research note on Friday, March 6th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $19.33.
Read Our Latest Stock Report on KVUE
Institutional Trading of Kenvue
A number of institutional investors have recently modified their holdings of KVUE. Norges Bank bought a new stake in shares of Kenvue during the 4th quarter valued at $756,862,000. Independent Franchise Partners LLP lifted its position in shares of Kenvue by 56.3% during the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company's stock valued at $830,527,000 after acquiring an additional 17,343,785 shares during the period. Sculptor Capital LP lifted its position in shares of Kenvue by 1,023.5% during the 4th quarter. Sculptor Capital LP now owns 12,886,328 shares of the company's stock valued at $222,289,000 after acquiring an additional 11,739,328 shares during the period. Capitolis Liquid Global Markets LLC lifted its position in shares of Kenvue by 1,116.8% during the 4th quarter. Capitolis Liquid Global Markets LLC now owns 10,950,999 shares of the company's stock valued at $188,905,000 after acquiring an additional 10,050,999 shares during the period. Finally, Cibc World Markets Corp bought a new stake in shares of Kenvue during the 4th quarter valued at $162,193,000. 97.64% of the stock is currently owned by institutional investors.
Kenvue Company Profile
(
Get Free Report)
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
